Candel Therapeutics (CADL) Total Liabilities (2020 - 2025)
Candel Therapeutics (CADL) posted Total Liabilities of $73.3 million for Q4 2025, up 443.81% sequentially from $13.5 million in Q3 2025, and up 80.75% YoY from $40.5 million in Q4 2024.
Candel Therapeutics (CADL) Total Liabilities (2020 - 2025) Analysis & Trends
Candel Therapeutics has reported Total Liabilities for 6 years, with the latest figure at $73.3 million in Q4 2025.
- Quarterly Total Liabilities rose 80.75% year-over-year to $73.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $73.3 million (up 80.75% YoY) and the FY2025 annual result came in at $73.3 million, up 80.75% from the prior year.
- Total Liabilities grew to $73.3 million in Q4 2025 per CADL's latest filing, from $13.5 million in the prior quarter.
- Over five years, Total Liabilities peaked at $73.3 million in Q4 2025 and troughed at $13.5 million in Q3 2025.
- A 5-year average of $31.1 million and a median of $28.5 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Liabilities surged 96.09% in 2021, then tumbled 63.36% in 2025.
- Over 5 years, Total Liabilities stood at $25.1 million in 2021, then grew by 19.58% to $30.0 million in 2022, then retreated by 5.07% to $28.5 million in 2023, then surged by 42.46% to $40.5 million in 2024, then jumped by 80.75% to $73.3 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $73.3 million, $13.5 million, and $15.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - | 73.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 73.27 Mn |
| Sep 30, 2025 | 13.47 Mn |
| Jun 30, 2025 | 15.76 Mn |
| Mar 31, 2025 | 21.23 Mn |
| Dec 31, 2024 | 40.54 Mn |
| Sep 30, 2024 | 36.77 Mn |
| Jun 30, 2024 | 36.46 Mn |
| Mar 31, 2024 | 25.24 Mn |
| Dec 31, 2023 | 28.46 Mn |
| Sep 30, 2023 | 27.04 Mn |
| Jun 30, 2023 | 27.94 Mn |
| Mar 31, 2023 | 27.59 Mn |
| Dec 31, 2022 | 29.98 Mn |
| Sep 30, 2022 | 32.88 Mn |
| Jun 30, 2022 | 33.23 Mn |
| Mar 31, 2022 | 37.80 Mn |
| Dec 31, 2021 | 25.07 Mn |
| Sep 30, 2021 | 32.97 Mn |
| Jun 30, 2021 | 24.86 Mn |
| Dec 31, 2020 | 12.78 Mn |